Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 6/20 | 0.46 |
| ▸ | ATRIP | Q8WXE1 | 3/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 6/20 | 0.34 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.34 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.34 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | TTK | P33981 | 1/20 | 0.32 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30797903 | 0.90 | ATR (0.50) | ATRATRIPCNR1BRD4DDB1 | |
| SCHEMBL30868992 | 0.89 | ATR (0.42) | ATRATRIPBRD4DDB1CRBN | |
| SCHEMBL30869097 | 0.85 | ATR (0.47) | ATRATRIPCNR1BRD4CA12 | |
| SCHEMBL30869149 | 0.85 | ATR (0.47) | ATRATRIPCNR1BRD4CA12 | |
| SCHEMBL30869082 | 0.84 | ATR (0.45) | ATRATRIPCNR1BRD4CA12 | |
| SCHEMBL30797746 | 0.82 | ATR (0.46) | ATRATRIPCNR1BRD4DDB1 | |
| SCHEMBL27378404 | 0.82 | ATR (0.46) | ATRATRIPCNR1BRD4DDB1 | |
| SCHEMBL30797688 | 0.81 | ATR (0.44) | ATRATRIPBRD4DDB1CRBN | |
| SCHEMBL30869132 | 0.81 | ATR (0.44) | ATRATRIPCNR1BRD4DDB1 | |
| SCHEMBL30797980 | 0.78 | ATR (0.49) | ATRATRIPCNR1BRD4DDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584249-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | Cambridge Enterprise Limited (GB) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052702-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |